The Orange Book is the key reference used to determine the bioequivalence of generic drugs, providing vital information on therapeutic equivalence evaluations. It ensures that generic drugs deliver the same clinical benefits as their brand-name counterparts. Other references like the Drug Facts and Comparisons, Red Book, and American Drug Index do not specifically address bioequivalence. ;
The Orange Book, or Approved Drug Products with Therapeutic Equivalence Evaluations, is the primary reference for determining the bioequivalence of generic drugs. It provides critical information on which generics are equivalent to their brand-name counterparts. Other reference materials do not focus on bioequivalence.
;